Press releases
The latest from Medimaps
Product launches, regulatory milestones, and company news, as it happens.
July 27, 2026
Medimaps Group has expanded its partnership with CARPL.ai, bringing TBS Reveal™ onto CARPL's marketplace alongside RBfracture™, giving radiology departments access to both AI applications through a single integration
June 17, 2026
The certification confirms that Medimaps’ QMS has been audited under a globally recognized program designed to streamline regulatory oversight while maintaining rigorous quality management expectations.
June 4, 2026
TBS Reveal™ is designed to help shift bone care from reaction to prevention: To surface fragility risk before the first fracture, rather than diagnosing osteoporosis only after a break has occurred.
May 28, 2026
Findings support the use of routine X-rays to help identify individuals at very high bone fragility risk who may benefit from further bone health evaluation.
March 2, 2026
Medimaps Group SA — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — and Radiobotics ApS, a leader in AI-powered musculoskeletal (MSK) radiology solutions, today announced that they have entered into a strategic merger agreement.
July 29, 2025
Medimaps announced a new clinical research partnership with the National Spine Health Foundation (NSHF), a nonprofit organization dedicated to patient education, research, and advocacy.
July 3, 2025
Medimaps — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — today announced the European launch of its MDR-cleared, next-generation TBS Osteo™ Advanced software. Following the product's launch in the United States the previous month, this milestone reflects the company's commitment to advancing osteoporosis detection and bone health management worldwide.
June 10, 2025
Medimaps — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — is further expanding its presence in the US with the launch of its FDA-cleared next-generation TBS Osteo™ Advanced software. This milestone reflects the company's commitment to advancing osteoporosis detection and bone health management in the US market with innovative solutions.
May 13, 2025
TBS included in national guidelines for diagnosis and treatment of osteoporosis in Slovakia
TBS® (Trabecular Bone Score®) has recently been included in the national guideline for the diagnosis and treatment of osteoporosis in Slovakia.
May 1, 2025
SimonMed Imaging integrates TBS Osteo into DXA scans across 80+ US locations
Medimaps announced that SimonMed Imaging has integrated TBS Osteo™ into its DXA scans, enhancing fracture risk assessment for patients across the US. This integration makes TBS® available to more people, supporting better bone health diagnostics.
January 27, 2025
Medimaps announced 510(k) clearance from the FDA and MDR certification in the EU for the latest version of its flagship software, TBS Osteo™. This next-generation software is designed to enhance bone microarchitecture evaluation, broaden patient eligibility, and improve connectivity within medical facilities.
September 27, 2024
Medimaps announced the presentation of new data on its AI deep learning software model to opportunistically detect bone fragility from conventional X-ray imaging, at the American Society for Bone and Mineral Research annual congress (ASBMR) .
Say hello, whether you're a clinician, a research partner, or an investor.